Recent Updates
Recently added Catalysts
CGON Positive Sentiment Score: 75/100

CG Oncology to Present at Upcoming Investor Conferences in May

Key Takeaway: CG Oncology, Inc. will present at two upcoming investor conferences in May 2026. CEO Arthur Kuan and COO Ambaw Bellete will participate in fireside chats at the Bank of America Health Care Conference on May 12 and the RBC Capital Markets Global Healthcare Conference on May 20. These events aim to enhance investor engagement and showcase the company's developments in bladder cancer therapies.

Market Sentiment Analysis

POSITIVE FACTORS

  • CG Oncology is actively engaging with investors through presentations.
  • The participation in major healthcare conferences highlights the company's visibility.
  • The focus on innovative immunotherapies for bladder cancer is promising.

Full Press Release Details

DALLAS, May 05, 2026 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON) today announced that Arthur Kuan, Chairman & Chief Executive Officer, and Ambaw Bellete, President & Chief Operating Officer, will participate in fireside chat presentations at the Bank of America Health Care Conference and the RBC Capital Markets Global Healthcare Conference this month. The details of the upcoming events are as follows:

Bank of America Health Care Conference 2026Date: Tuesday, May 12, 2026Presentation Time: 10:40 AM – 11:10 AM PTLocation: Las Vegas, NV

RBC Capital Markets Global Healthcare ConferenceDate: Wednesday, May 20, 2026Presentation Time: 2:35 PM – 3:00 PM ETLocation: New York, NY

Interested parties may access the live audio webcast for the conferences from theInvestor Relations sectionof the company's website atwww.cgoncology.com. The webcast replays will be available shortly after the conclusion of the live presentations and archived for approximately 90 days.
About CG OncologyCG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. CG Oncology sees a world where urologic cancer patients may benefit from our innovative immunotherapies to live with dignity and have an enhanced quality of life. To learn more, please visit: www.cgoncology.com.

ContactsMediaSarah ConnorsVice President, Communications and Patient Advocacy, CG Oncologysarah.connors@cgoncology.com

Investor RelationsMegan KnightVice President, Investor Relations, CG Oncologymegan.knight@cgoncology.com

Frequently Asked Questions

When is the Bank of America Health Care Conference?

The Bank of America Health Care Conference is on May 12, 2026.

Who will represent CG Oncology at the conferences?

Arthur Kuan and Ambaw Bellete will represent CG Oncology.

Where can I access the conference webcasts?

The webcasts can be accessed from the Investor Relations section of CG Oncology's website.

What is CG Oncology focused on developing?

CG Oncology focuses on developing therapies for bladder cancer.

Last updated: May 5, 2026